Cormorant Asset Management, LP - Former 10% Owner at Monte Rosa Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
Former 10% Owner
Stock Symbol
GLUE on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Cormorant Asset Management, LP since 8/26/2023

Holdings reported by Cormorant Asset Management, LP for Monte Rosa Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 3.2M $60.8M $19.00 Jun 28, 2021 Indirect
Series B Convertible Preferred Stock 0 $2.00 Jun 28, 2021 Indirect Common Stock
Series C Convertible Preferred Stock 0 $2.96 Jun 28, 2021 Indirect Common Stock

Transactions reported by Cormorant Asset Management, LP for Monte Rosa Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.